The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 108, 172-178
Abstract
No abstract availableKeywords
Funding Information
- Swiss National Science Foundation (31003A_138382)
This publication has 50 references indexed in Scilit:
- Anticonvulsant effects of structurally diverse GABAB positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening modelNeuropharmacology, 2016
- The GABAB receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in ratsNeuropharmacology, 2009
- Prevalence of chronic pain with neuropathic characteristics in the general populationPain, 2008
- Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remainBritish Journal Of Neurosurgery, 2008
- GABAB receptor: a site of therapeutic benefitCurrent Opinion in Pharmacology, 2006
- The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB ReceptorJournal of Biological Chemistry, 2004
- Molecular Structure and Physiological Functions of GABABReceptorsPhysiological Reviews, 2004
- Comparative immunohistochemical localisation of GABAB1a, GABAB1b and GABAB2 subunits in rat brain, spinal cord and dorsal root ganglionNeuroscience, 2001
- Baclofen inhibits more effectively C-afferent than Aδ-afferent glutamatergic transmission in substantia gelatinosa neurons of adult rat spinal cord slicesPain, 2000
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988